BioCentury
ARTICLE | Company News

AltraVax, Maxygen deal

March 1, 2010 8:00 AM UTC

Newco AltraVax received exclusive, worldwide rights to use Maxygen's MolecularBreeding technology for vaccine identification and development. The technology uses directed evolution, a process of recom...